Michael Burry's Scion Asset Management ended the first quarter more bullish on companies across different sectors and ...

Scion Asset Management, founded by Michael Burry of "Big Short" fame, started new positions in consumer and healthcare names including lululemon athletica (LULU ...

At the same time, more than half of the US-listed stocks covered by Morningstar that reported earnings as of Aug. 11 beat ...

We closed out July 2025 in Boston alongside several of our Axinn colleagues attending the American Conference Institute’s ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a clinical study ...

Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

Regeneron Pharmaceuticals, Inc. reported a stellar quarter, with earnings hitting $12.89 per share, crushing the $8.43 expected by analysts. Citizens Financial Group Inc. RI reduced its stake in the ...

Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Swiss National Bank trimmed its stake in Regeneron Pharmaceuticals, Inc. by a modest 0.5%. Despite this, Regeneron's share ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the top most undervalued biotech stocks to buy now. Guggenheim ...

Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...